felin
infecti
periton
fip
almost
invari
fatal
felin
coronaviru
fcov
induc
diseas
thought
aris
combin
viral
mutat
overexuber
immun
respons
natur
initi
enter
fcov
infect
may
remain
subclin
result
mild
enter
sign
develop
fip
cat
may
also
carri
viru
system
advers
effect
studi
screen
mesenter
lymph
node
mln
presum
first
site
fcov
spread
intestin
regardless
viraemia
chang
transcript
panel
innat
immun
respons
mediat
respons
system
fcov
infect
fip
aim
identifi
key
pathway
trigger
fcov
cat
without
fip
latter
without
fcov
infect
mln
compar
higher
express
level
fip
found
tolllik
receptor
tlr
part
first
line
defenc
suggest
respons
viral
structur
protein
viral
nucleic
acid
express
gene
encod
inflammatori
cytokin
chemokin
includ
interleukin
il
tumour
necrosi
factor
tnf
interferon
ifn
ifnb
ifng
higher
cat
fip
consist
inflammatori
pathway
activ
express
gene
encod
transcript
factor
regul
signal
pathway
particularli
interferon
also
higher
among
cat
without
fip
differ
virusposit
virusneg
mln
howev
express
higher
infect
suggest
direct
viral
effect
studi
provid
evid
tlr
involv
respons
fcov
could
open
new
avenu
therapeut
approach
felin
infecti
periton
fip
wellknown
wide
distribut
coronavirusinduc
diseas
felid
yet
effect
vaccin
viabl
treatment
option
fip
almost
invari
fatal
understand
pathogenet
immunolog
mechan
involv
diseas
develop
crucial
aid
chanc
combat
fip
identifi
novel
avenu
possibl
treatment
initi
enter
infect
felin
coronaviru
fcov
may
spread
beyond
intestin
result
monocyteassoci
viraemia
without
develop
fip
case
progress
fip
may
time
lag
week
year
viral
host
factor
combin
turn
initi
usual
subclin
enter
overt
immunemedi
diseas
pedersen
et
al
kipar
meli
much
research
focuss
viral
mutat
partial
elucid
function
variou
viral
protein
pathogenesi
fip
viral
spike
protein
gene
particular
interest
switch
methionin
leucin
l
amino
acid
residu
strongli
associ
gain
virul
chang
et
al
second
switch
serin
alanin
amino
acid
residu
distinguish
tissueassoci
fcov
small
subset
fip
case
fcov
shed
faec
healthi
cat
chang
et
al
mutat
sinc
associ
system
spread
fcov
rather
provid
proof
virul
porter
et
al
barker
et
al
felten
et
al
two
form
subsequ
refer
system
enter
fcov
earli
experi
demonstr
cat
suscept
fcov
infect
even
known
pathogen
strain
pedersen
boyl
indic
import
host
genet
factorsimmun
mechan
diseas
develop
recent
shown
cultur
monocyt
differ
cat
vari
abil
sustain
viral
replic
suggest
subset
anim
resist
diseas
dewerchin
et
al
teke
et
al
monocytesmacrophag
cell
type
beyond
enterocyt
may
infect
fcov
also
key
cell
innat
immun
defenc
system
abl
detect
pathogenassoci
molecular
pattern
pamp
trigger
number
intracellular
signal
pathway
lead
activ
antivir
state
host
abba
et
al
chief
amongst
pathway
trigger
engag
tolllik
receptor
tlr
highli
evolutionarili
conserv
membranebound
pathogen
recognit
receptor
prr
lester
li
presenc
cell
surfac
membran
intern
membranebound
vesicl
allow
detect
extern
intern
pamp
ligand
includ
associ
virus
bacteria
fungi
arpaia
barton
downstream
mediat
includ
inflammatori
cytokin
interferon
assess
cat
fip
sometim
conflict
result
dean
et
al
kipar
et
al
interferon
inflammatori
cytokin
interleukin
il
activ
member
signal
transduc
regul
transcript
stat
famili
downstream
effect
replic
differenti
inflammatori
potenti
aaronson
horvath
cat
compromis
immun
system
appear
suscept
fip
paradox
lesion
caus
excess
immun
respons
pedersen
pedersen
kipar
meli
attribut
least
part
increas
viral
replic
immunosuppress
anim
therefor
increas
likelihood
viral
mutat
occur
accumul
poland
et
al
tlr
associ
suscept
mani
diseas
includ
chronic
inflammatori
viral
specif
coronavir
diseas
eg
sever
acut
respiratori
syndrom
sar
dosch
et
al
intriguingli
though
tlr
stimul
antagonismknockout
contribut
exacerb
diseas
differ
context
exist
consider
crossov
receptor
potenti
ligand
arpaia
barton
fcov
abl
leav
intestin
mesenter
lymph
node
mln
presum
first
site
viral
spread
potenti
repres
interfac
local
system
immun
respons
support
assumpt
fip
case
present
mln
lesion
kipar
et
al
therefor
chose
mln
organ
interest
aim
compar
key
mediat
innat
immun
system
uninfect
cat
fcovinfect
cat
without
fip
hypothes
addit
excess
proinflammatori
cytokin
respons
would
defici
interferon
respons
aim
gain
insight
tlr
pathway
involv
trigger
respons
also
wish
evalu
presenc
signific
previous
publish
viral
gene
variat
determin
whether
connect
host
immun
respons
could
detect
studi
undertaken
cat
seen
initi
patient
univers
small
anim
clinic
local
veterinari
practic
bristol
uk
zurich
switzerland
human
destroy
without
fip
clinic
reason
unrel
studi
tabl
postmortem
examin
perform
cat
owner
consent
sampl
mln
collect
rnalat
qiagen
hombrechtikon
switzerland
within
h
euthanasia
store
c
use
bristol
case
form
part
univers
bristol
fip
biobank
built
resourc
multipl
studi
mani
case
util
previous
porter
et
al
barker
et
al
group
compris
control
cat
confirm
fip
altern
confirm
diagnosi
tabl
group
consist
cat
confirm
fip
tabl
diagnosi
fip
base
relev
clinic
find
compat
gross
andor
histolog
lesion
togeth
immunohistolog
demonstr
fcov
antigenposit
macrophag
within
typic
lesion
kipar
et
al
immunohistochemistri
carri
previous
describ
kipar
et
al
use
mous
monoclon
primari
antibodi
clone
sc
santa
cruz
heidelberg
germani
base
result
revers
transcriptas
quantit
polymeras
chain
reaction
rtqpcr
fcov
undertaken
mln
group
subdivid
fcov
posit
fcov
neg
rna
extract
carri
use
rneasi
plu
minikit
qiagen
accord
manufactur
protocol
briefli
mg
mln
tissu
disrupt
extract
buffer
use
tissu
homogen
mixermil
retsch
haan
germani
sec
hz
oncolumn
extract
elut
rna
pilot
test
reveal
signific
genom
dna
contamin
remain
option
dnase
step
includ
prior
use
superscript
iv
vilo
kit
thermofish
scientif
waltham
massachusett
usa
cdna
synthesi
follow
manufactur
instruct
order
avoid
possibl
interfer
rtqpcr
result
start
rna
level
equilibr
sampl
ngml
use
nanodrop
thermofish
scientif
sampl
dilut
prior
rtqpcr
taqman
rtqpcr
perform
appli
biosystem
fast
pcr
system
thermofish
scientif
use
newli
develop
previous
publish
primer
probe
protocol
fcov
felin
tlr
stat
interferon
ifn
b
g
tumour
necrosi
factor
tnf
cxc
motif
chemokin
cc
motif
chemokin
ligand
transform
growth
factor
tgf
glyceraldehyd
dehydrogenas
gapdh
refer
gene
tabl
gene
chosen
base
previou
experi
laboratori
follow
refer
gene
comparison
optim
primer
probe
manufactur
microsynth
balgach
switzerland
hydrolysi
probe
label
report
dye
fam
quencher
tamra
primer
probe
newli
develop
design
use
primer
express
softwar
thermo
fisher
scientif
span
exoneexon
junction
test
specif
convent
pcr
test
sampl
gel
electrophoresi
sequenc
result
extract
band
microsynth
evalu
use
ncbi
blast
condit
rtqpcr
except
omiss
probe
primer
concentr
step
nm
vari
primerprob
concentr
test
determin
optim
effici
dynam
rang
well
replic
use
sampl
dilut
seri
final
protocol
tabl
effici
previous
publish
test
system
omit
convent
rtpcr
step
reaction
compris
ml
taqman
fast
univers
master
mix
thermofish
scientif
ml
cdna
primer
probe
volum
per
tabl
made
ml
rnasefre
water
thermal
profil
rtqpcr
c
min
c
min
cycl
c
sec
c
min
sampl
run
duplic
sampl
discord
result
repeat
data
collect
occur
extens
phase
c
appropri
control
includ
run
appli
biosystem
softwar
use
visual
result
alloc
quantif
cycl
c
q
sampl
threshold
equilibr
run
target
particular
codon
interest
within
fcov
gene
chang
et
al
refer
sequenc
use
origin
paper
mutat
question
appear
posit
rather
previous
describ
refer
subsequ
former
number
follow
initi
fcov
rtqpcr
posit
sampl
analys
previou
studi
porter
et
al
barker
et
al
underw
addit
convent
rtpcr
sanger
sequenc
target
gene
region
interest
pcr
perform
use
previous
publish
degener
primer
porter
et
al
reaction
compris
ml
phusion
flash
master
mix
thermofish
scientif
ml
cdna
mm
forward
revers
primer
made
ml
rnasefre
water
reaction
run
profession
thermocycl
biometra
gmbh
ottingen
germani
follow
thermal
profil
c
sec
cycl
c
sec
c
sec
c
sec
follow
c
min
appropri
control
includ
run
reaction
product
underw
gel
electrophoresi
band
appropri
size
extract
use
genejet
gel
extract
kit
thermofish
scientif
submit
sanger
sequenc
commerci
laboratori
microsynth
band
visibl
reaction
repeat
use
cycl
product
subject
gel
electrophoresi
sampl
still
appear
neg
cut
region
expect
band
purifi
resubject
pcr
bioinformat
softwar
geneiou
biomatt
limit
silkeborg
denmark
use
map
result
sequenc
refer
gene
fcov
access
number
chang
et
al
rel
mrna
transcript
level
calcul
use
compar
c
q
method
pfaffl
c
q
target
first
normal
gapdh
endogen
refer
dc
q
express
rel
dc
q
mean
calibr
fcov
rtqpcr
result
mean
instead
use
calibr
allow
visual
graphic
statist
programm
spss
statist
ibm
armonk
new
york
usa
use
analys
graphic
data
present
data
first
assess
normal
use
shapiroewilk
test
almost
data
fail
test
nonparametr
measur
appli
twotail
mannewhitney
test
signific
level
p
use
compar
result
group
target
molecul
firstli
cat
without
fip
versu
compar
follow
comparison
three
group
turn
within
comparison
made
cat
without
cavitari
effus
without
histolog
observ
fip
lesion
mln
correl
rel
fcov
level
inflammatori
mediat
gene
express
level
also
individu
inflammatori
mediat
gene
express
level
analys
within
use
onetail
spearman
rank
test
cut
p
use
p
indic
weak
correl
signal
cat
shown
tabl
mln
sampl
cat
fip
posit
fcov
n
cat
without
fip
also
posit
fcov
rtqpcr
result
assign
new
subgroup
howev
rel
fcov
load
clearli
significantli
lower
fig
none
cat
exhibit
histolog
chang
suggest
fip
tissu
examin
includ
mln
avail
histolog
seven
inflamm
tabl
primer
probe
sequenc
use
rtqpcr
convent
rtpcr
refer
access
number
primer
probe
sequenc
tagling
immun
respons
felin
coronaviru
aetiolog
observ
mln
two
cat
none
anim
sampl
also
neg
fcov
antigen
immunohistochemistri
mln
avail
histolog
examin
cat
fip
case
exhibit
typic
pyogranulomat
lesion
without
associ
seros
lesion
lymph
node
capsul
eg
serofibrin
granulomat
seros
sampl
typic
pyogranulomat
lesion
also
show
fcov
antigen
lesion
macrophag
fig
b
seven
mln
typic
lesion
among
one
case
fcov
antigen
detect
low
number
macrophag
within
margin
sinu
suggest
earli
lesion
fig
signific
differ
fcov
load
found
mln
without
lesion
although
lesion
tendenc
higher
fcov
level
fig
cat
fip
exhibit
effus
tabl
associ
higher
rel
fcov
load
mln
comparison
cat
without
effus
n
data
avail
two
cat
order
evalu
effect
fcov
infect
fip
target
gene
transcript
first
compar
comparison
three
group
assess
target
gene
describ
accord
posit
immun
signal
pathway
first
line
receptor
inflammatori
mediat
signal
transduc
detail
result
provid
tabl
tolllik
receptor
rel
gene
transcript
level
significantli
higher
within
differ
virusposit
virusneg
mln
tlr
howev
gene
express
although
elev
significantli
higher
fig
indic
signific
level
p
first
three
column
second
group
comparison
significantli
higher
case
eg
versu
level
higher
fip
column
valu
present
group
case
higher
absent
group
cat
gene
transcript
level
compar
mln
without
fip
lesion
relat
presenc
effus
signific
differ
found
higher
express
mln
lesion
fig
tabl
contrast
express
appear
slightli
lower
cat
effus
fig
possibl
trend
reach
signific
slightli
higher
express
level
mln
lesion
gene
express
level
slightli
lower
fig
investig
found
gene
express
level
mln
without
lesion
also
slightli
higher
level
similar
mln
lesion
suggest
potenti
neg
regul
fcov
fig
cytokin
chemokin
rel
tnfa
ifna
b
g
gene
transcript
level
significantli
higher
compar
fig
none
show
signific
differ
cytokin
cluster
togeth
howev
tnfa
ifng
appear
cluster
slightli
two
group
suggest
possibl
intermedi
stage
fig
group
fold
fig
boxplot
rel
level
tlr
gene
express
group
amount
target
calcul
use
fgapdh
intern
refer
gene
express
n
fold
differ
rel
mean
calibr
box
depict
median
interquartil
iq
rang
whisker
extend
highest
lowest
valu
within
iq
rang
outlier
beyond
individu
mark
mark
signific
differ
individu
group
p
join
bar
whole
repres
rel
gene
express
level
among
mln
cat
without
effusionsles
fig
boxplot
rel
level
cytokin
chemokin
gene
express
group
amount
target
calcul
use
fgapdh
intern
refer
gene
express
n
fold
differ
rel
mean
calibr
box
depict
median
interquartil
iq
rang
whisker
extend
highest
lowest
valu
within
iq
rang
outlier
beyond
individu
mark
mark
signific
differ
individu
group
p
join
bar
whole
repres
rel
gene
express
level
among
mln
cat
without
effusionsles
differ
chemokin
gene
express
level
mainli
rang
pyrogen
cytokin
tnfa
rare
exceed
tgfb
gene
transcript
level
show
intergroup
differ
fig
tabl
ifng
possibl
trend
toward
increas
transcript
reach
signific
observ
mln
lesion
compar
without
fig
signal
transduc
activ
transcript
gene
express
level
significantli
higher
transcript
factor
gene
express
level
also
higher
significantli
gene
express
level
similar
across
group
fig
gene
express
level
significantli
higher
cat
effus
fig
tabl
insignific
trend
higher
effus
fig
major
gene
target
elev
also
show
signific
posit
correl
rel
viral
load
supplementari
tabl
includ
cytokin
togeth
ifnb
ifng
p
ifna
gene
express
show
weaker
correl
p
tgfb
tnfa
gene
express
show
correl
weak
although
signific
neg
correl
tabl
express
gene
encod
holi
triniti
autoimmun
camporeal
poli
significantli
correl
despit
latter
two
show
correl
fcov
cat
shown
rtqpcr
carri
fcov
mln
analys
gene
sequenc
follow
convent
pcr
remain
two
cat
cat
possibl
obtain
sampl
suffici
qualiti
even
repeat
attempt
tabl
cat
fip
one
infect
fcov
serotyp
previous
describ
gene
sequenc
character
applic
herrewegh
et
al
barker
et
al
twentysix
mln
sampl
contain
viru
encod
leucin
cdna
sequenc
ttg
group
amount
target
calcul
use
fgapdh
intern
refer
gene
express
n
fold
differ
rel
mean
calibr
box
depict
median
interquartil
iq
rang
whisker
extend
highest
lowest
valu
within
iq
rang
outlier
beyond
individu
mark
mark
signific
differ
individu
group
p
join
bar
whole
repres
rel
gene
express
level
among
mln
cat
without
effus
lesion
c
c
c
c
c
posit
correl
signific
level
p
posit
correl
signific
level
p
neg
correl
signific
level
p
ctg
tta
remain
three
cat
encod
methionin
codon
cdna
sequenc
atg
result
shown
tabl
eight
sequenc
obtain
cat
encod
leucin
three
case
encod
methionin
codon
two
encod
alanin
codon
third
encod
serin
tabl
small
methionin
group
size
n
includ
one
cat
carri
enter
viru
consid
valid
statist
comparison
leucin
group
system
viru
instead
individu
case
plot
reveal
methionin
group
fall
within
rang
leucin
group
everi
target
includ
fcov
load
fig
predict
previou
studi
result
present
investig
confirm
complex
effect
fcov
immun
system
associ
fip
diseas
caus
exagger
immun
respons
fcov
well
known
cat
also
carri
fcov
system
without
develop
fip
meli
et
al
assess
key
mediat
innat
immun
respons
focuss
mln
like
first
site
infect
beyond
intestin
one
main
site
viral
persist
experiment
infect
healthi
anim
kipar
et
al
compar
fcovposit
lesionfre
mln
cat
affect
diseas
fip
fcovneg
cat
without
fip
cat
fip
aim
separ
direct
viral
effect
host
effect
contribut
fip
natur
set
fip
present
spectrum
diseas
variabl
durat
rather
discret
clinic
pictur
patholog
featur
also
vari
reflect
variat
organ
involv
presenc
effus
case
cohort
therefor
also
want
assess
whether
inflammatori
mediat
product
mln
show
correl
form
diseas
although
vascular
permeabl
larg
extent
cytokin
mediat
takano
et
al
found
upregul
cytokin
gene
role
vascular
permeabl
fip
case
inflammatori
mediat
gene
express
profil
mln
differ
minim
cat
without
effus
suggest
mln
unlik
make
larg
system
contribut
vascular
permeabl
similarli
safi
et
al
evalu
inflammatori
mediat
within
peripher
blood
mononuclear
cell
fip
cat
without
effus
found
littl
consist
pattern
distinguish
effus
without
studi
therefor
provid
although
indirect
support
vascular
endotheli
growth
factor
previous
shown
correl
degre
effus
fip
key
phenomenon
takano
et
al
interestingli
presenc
absenc
histolog
fip
lesion
correl
mani
signific
differ
mediat
gene
express
alongsid
surprisingli
although
fcov
level
appear
higher
associ
lesion
significantli
may
partli
explain
lack
signific
differ
mediat
gene
express
addit
entir
exclud
area
mln
sampl
rna
extract
within
fip
lesion
vice
versa
altern
explan
lack
signific
differ
gene
express
mediat
mln
mani
exhibit
higher
overal
level
fip
would
system
stimul
upregul
inflammatori
mediat
relev
local
lesionspecif
stimul
final
trend
occasion
observ
case
without
effus
mln
lesion
compar
lack
signific
may
also
due
small
group
size
subgroup
creat
limit
studi
mln
cat
without
fip
significantli
lower
viral
load
counterpart
cat
fip
confirm
previou
find
natur
infect
cat
fip
report
carri
higher
viral
load
haemopoiet
lymphoid
tissu
includ
mln
asymptomat
fcovinfect
cat
kipar
et
al
without
diseas
howev
presenc
absenc
fcov
mln
seem
influenc
transcript
level
target
immun
mediat
would
indic
main
host
respons
greater
influenc
direct
viral
effect
still
except
even
among
mediat
attain
signific
ifng
tnfa
show
trend
toward
higher
gene
express
level
fcovposit
mln
suggest
least
modest
direct
viral
effect
may
mask
low
group
number
requir
larger
sampl
size
confirm
refut
anoth
studi
limit
composit
group
field
case
possibl
control
confound
factor
eg
ensur
control
case
free
inflammatori
process
fip
case
similar
diseas
stage
cat
initi
subject
fcov
infect
pressur
inflammatori
cytokin
previous
studi
fip
conflict
result
possibl
depend
variat
diseas
form
anim
includ
differ
studi
andor
type
sampleorgan
evalu
tnfa
gene
transcript
exampl
found
decreas
mln
cat
fip
compar
fcovfre
specif
pathogenfre
cat
gene
express
elev
kipar
et
al
present
studi
gene
express
three
pyrogen
cytokin
tnfa
upregul
mln
fip
well
stimul
lymphocyt
prolifer
also
found
significantli
higher
transcript
level
monocyterecruit
chemokin
found
upregul
crandellere
felin
kidney
cell
vitro
fcov
infect
harun
et
al
indic
mechan
monocyt
recruit
direct
viral
effect
result
confirm
relev
vivo
recruit
monocyt
infect
cell
type
potenti
amplifi
step
worthi
investig
increas
inflammatori
cytokin
gene
transcript
support
observ
overexuber
inflammatori
respons
key
factor
develop
progress
fip
express
gene
encod
antiinflammatori
cytokin
contrast
upregul
fip
impli
local
brake
inflammatori
process
line
previou
find
express
higher
spleen
healthi
fcovinfect
cat
mln
kipar
et
al
gene
express
interferon
also
higher
fip
ifng
one
cytokin
show
intermedi
level
infect
asymptomat
cat
studi
type
ii
interferon
major
antivir
role
innat
immun
system
ifng
particular
interest
fip
level
potenti
protect
cytokin
tend
low
peripher
blood
diseas
anim
host
gene
polymorph
identifi
may
contribut
resist
diseas
gelain
et
al
hsieh
chueh
similarli
appar
lack
impact
mediat
level
presenc
lesion
effus
fip
suggest
mln
ifn
product
local
effect
tlr
use
target
therapi
number
diseas
human
medicin
adjuv
inhibitor
howev
veterinari
medicin
lag
behind
respect
hennessi
et
al
klingemann
identifi
increas
gene
express
level
tlr
fip
fcov
infect
respect
indic
possibl
role
molecul
fip
henc
identifi
potenti
target
fip
control
assess
protein
level
would
use
avenu
investig
howev
particularli
challeng
felin
studi
owe
lack
avail
appropri
antibodi
mammal
tlr
locat
cell
membran
tlr
found
intracytoplasm
vesicl
commonli
profession
antigen
present
cell
lester
li
togeth
tlr
compris
famili
roach
et
al
latter
three
receptor
aros
evolutionari
gene
duplic
hugh
piontkivska
hennessi
et
al
abl
signal
heterodim
cofamili
member
order
allow
wider
rang
antigen
recognit
typic
respons
detect
bacteri
fungal
compon
beutler
link
detect
sarscov
protein
vitro
dosch
et
al
upregul
fip
could
indic
fcov
protein
also
abl
act
ligand
classic
detect
lipopolysaccharid
howev
one
studi
link
protect
murin
coronaviru
mice
found
exhibit
greater
suscept
murin
hepat
viru
infect
precis
mechan
establish
case
involv
inflammatori
cell
influx
mice
khanolkar
et
al
protect
effect
observ
studi
despit
upregul
gene
express
mln
associ
fip
although
individu
effect
case
separ
mediat
milieu
gene
express
elev
mln
cat
fip
instead
increas
fcovposit
mln
cat
without
fip
consid
previou
vitro
studi
found
reduc
viral
replic
stimul
synthet
cpg
ligand
prior
fcov
infect
roberttissot
et
al
increas
gene
express
fcovinfect
cat
without
fip
could
indic
protect
effect
may
even
help
prevent
develop
diseas
stimul
coinfecti
agent
could
therefor
also
hypothes
protect
fip
along
line
coinfect
must
also
consid
possibl
altern
explan
rais
gene
express
level
tlr
typic
associ
bacteri
infect
enter
coronaviru
infect
gener
inflammatori
state
induc
fip
may
increas
permeabl
intestin
barrier
microorgan
result
tlr
stimul
would
therefor
viru
induc
third
altern
upregul
endogen
ligand
stimul
report
respons
alarmin
releas
damag
cell
van
beijnum
et
al
altern
also
fit
upregul
gene
express
lesion
mln
compar
nonlesion
mln
fip
known
ligand
tlr
would
predict
trigger
infect
fcov
ssrna
viru
trigger
tlr
possess
doublestrand
rna
intermedi
replic
phase
trigger
arpaia
barton
upregul
occur
fip
suggest
either
lack
appropri
trigger
known
show
differ
overlap
specif
dsrna
intermedi
replic
minor
viral
rna
present
jensen
thomsen
viru
abl
inhibit
tlr
transcript
sarscov
known
inhibit
signal
via
papainlik
proteas
activ
plpro
li
et
al
mechan
may
also
contribut
fcov
infect
would
expect
affect
signal
pathway
rather
tlr
mrna
level
directli
cat
fip
observ
slightli
lower
gene
transcript
mln
typic
fip
lesion
compar
mln
without
lesion
level
seen
mln
cat
without
fip
could
indic
gener
system
stimulu
upregul
fip
counteract
local
viral
inhibit
prior
stimul
also
shown
vitro
contribut
defenc
murin
coronaviru
via
type
interferon
induct
mazaleuskaya
et
al
anoth
potenti
avenu
futur
fip
research
larger
sampl
popul
particular
larger
number
system
infect
cat
without
fip
might
reveal
signific
intergroup
differ
stat
transcript
factor
key
part
antivir
pathway
mediat
mani
downstream
ifn
effect
aaronson
horvath
also
link
coronaviru
infect
eg
knockout
mice
show
markedli
increas
suscept
sarscov
avian
infecti
bronchiti
coronaviru
use
inhibit
ifn
respons
frieman
et
al
kint
et
al
gene
transcript
level
correl
type
ii
interferon
transcript
level
respect
studi
virusposit
mln
cat
without
fip
level
latter
significantli
well
ifng
level
lay
two
group
show
level
ifn
downstream
transcript
factor
close
link
interestingli
gene
express
level
significantli
higher
mln
cat
fip
effus
find
readili
explain
link
upregul
link
increas
vascular
permeabl
maruo
et
al
nan
et
al
howev
gene
upregul
cohort
suggest
respons
lie
anoth
pathway
result
gene
codon
mutat
analysi
add
weight
recent
find
mutat
refer
present
studi
due
reevalu
refer
sequenc
like
contribut
system
spread
confer
pathogen
chang
et
al
porter
et
al
indic
host
andor
viral
factor
requir
develop
fip
precis
activ
virusinfect
monocyt
prerequisit
set
fip
vascul
kipar
meli
like
owe
low
viral
rna
level
within
mln
cat
without
fip
obtain
adequ
sequenc
group
prove
problemat
research
experienc
similar
problem
often
find
fcov
rtpcrposit
sampl
cat
without
fip
amen
sequenc
felten
et
al
lack
fcov
antigen
express
cat
unexpect
reflect
rariti
infect
cell
andor
low
viru
load
infect
cell
line
result
previou
studi
found
rare
posit
macrophag
mln
experiment
persistentlyinfect
cat
kipar
et
al
possibl
compar
statist
induc
immun
respons
virus
show
protein
amino
acid
variat
codon
one
cat
enter
form
futur
outcom
fcov
infect
cat
without
fip
succumb
diseas
unknown
contribut
yet
defin
viral
factor
cat
may
remain
carrier
demonstr
transit
phase
later
develop
diseas
howev
base
observ
activ
gene
encod
tlr
mln
associ
neg
outcom
ie
fip
carrier
anim
upregul
gene
encod
ifng
particularli
myriad
opportun
direct
cell
fate
display
intermedi
level
upregul
mln
carriertransit
group
associ
widespread
increas
mediat
inflamm
studi
start
determin
extent
involv
prr
fip
downstream
effect
transcript
alter
must
investig
howev
result
reinforc
need
balanc
immun
respons
viru
hypothesi
moder
respons
cat
without
fip
part
key
control
viru
balanc
lost
anim
may
risk
succumb
diseas
measur
cytokin
mrna
express
skin
normal
cat
cat
allerg
skin
diseas
veterinari
immunolog
immunopatholog
takano
